Opportunity Information: Apply for RFA AI 22 067

The National Institutes of Health (NIH) is soliciting applications for the International Centers of Excellence for Malaria Research (ICEMR) Program under Funding Opportunity Number RFA AI 22 067. This is a discretionary health research opportunity funded as a cooperative agreement (U19), meaning awardees should expect substantial scientific or programmatic involvement from NIH staff during the life of the project. The FOA is explicitly marked "Clinical Trial Not Allowed," so the supported work must be structured as research that does not meet NIH's definition of a clinical trial, even if it involves human data or samples (for example, observational studies or non-interventional research, depending on how the project is designed).

At its core, the ICEMR Program is meant to build and sustain a multidisciplinary, international network of research centers based in malaria-endemic settings. The research focus is twofold. First, centers are expected to deepen understanding of malaria pathogenesis, epidemiology, and transmission, which can include questions about how infections cause disease, how malaria spreads in real-world environments, and how patterns of risk change across seasons, geographies, and populations. Second, centers are expected to generate evidence that evaluates and optimizes interventions and informs the development of new tools and strategies aimed at malaria control, elimination, and eventual eradication. In practical terms, the program is designed to link basic, translational, and population-level research so that findings can directly shape the way malaria programs and future technologies are designed and used.

A defining feature of this FOA is where and how the work must be carried out. The supported research is intended to be conducted primarily in countries where malaria is endemic, and the application must demonstrate significant involvement of local and regional researchers in the study design, development, and execution. This is more than a general encouragement of collaboration; the program is structured to ensure that endemic-country investigators and institutions are integral partners with meaningful roles in leadership, scientific decision-making, and implementation. Proposals that rely heavily on external leadership without clear, substantive engagement and capacity integration in-country would be misaligned with the intent of the initiative.

Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other entities. The FOA also highlights additional eligible groups such as non-domestic (non-U.S.) entities (foreign organizations), regional organizations, U.S. territories or possessions, faith-based or community-based organizations, and multiple categories of minority-serving and tribal-serving institutions, including HBCUs, Hispanic-serving institutions, AANAPISIs, Alaska Native and Native Hawaiian Serving Institutions, and Tribally Controlled Colleges and Universities. This wide eligibility reflects the program's goal of building strong, locally grounded consortia that can combine scientific depth with operational reach in endemic settings.

From the funding details provided, the award ceiling is listed as $800,000, and the CFDA (Assistance Listing) number is 93.855. The original application closing date was May 4, 2023, and the FOA record shows a creation date of November 22, 2022. As a cooperative agreement, applicants should plan for an active partnership model with NIH, where milestones, data sharing expectations, and coordination across the broader ICEMR network are often central to how the program operates. Overall, this opportunity is aimed at supporting well-integrated research centers that can produce actionable knowledge about malaria biology and transmission while strengthening research leadership and capability in the regions most affected by the disease.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855.
  • This funding opportunity was created on 2022-11-22.
  • Applicants must submit their applications by 2023-05-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $800,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AI 22 067

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs) - NIH International Centers of Excellence for Malaria Research (ICEMR) Program (RFA AI 22 067)

What is this funding opportunity?

This opportunity is the National Institutes of Health (NIH) solicitation for applications to the International Centers of Excellence for Malaria Research (ICEMR) Program under Funding Opportunity Number (FON) RFA AI 22 067.

What type of award is NIH offering?

NIH is offering a cooperative agreement (U19). A cooperative agreement is different from a standard grant because NIH staff are expected to have substantial scientific or programmatic involvement during the project period.

What does it mean that this is a cooperative agreement (U19)?

It means awardees should expect an active partnership model with NIH. Based on the description provided, this can include NIH involvement related to milestones, expectations for data sharing, and coordination across the broader ICEMR network.

Are clinical trials allowed under this FOA?

No. The FOA is explicitly marked "Clinical Trial Not Allowed." Supported work must be structured so it does not meet NIH's definition of a clinical trial.

Can research still involve human data or human samples?

Yes, as long as the study is designed so it does not meet NIH's definition of a clinical trial. The description notes examples such as observational studies or other non-interventional research, depending on how the project is designed.

What is the main purpose of the ICEMR Program?

The ICEMR Program is intended to build and sustain a multidisciplinary, international network of research centers based in malaria-endemic settings. The centers are expected to generate knowledge that can directly shape malaria programs and future technologies.

What research topics are centers expected to address?

The research focus is described as twofold: (1) deepening understanding of malaria pathogenesis, epidemiology, and transmission; and (2) generating evidence that evaluates and optimizes interventions and informs the development of new tools and strategies for malaria control, elimination, and eventual eradication.

What does the FOA say about malaria pathogenesis, epidemiology, and transmission research?

The FOA emphasizes questions such as how infections cause disease, how malaria spreads in real-world environments, and how patterns of risk change across seasons, geographies, and populations.

What does the FOA mean by evaluating and optimizing interventions?

Based on the description provided, centers are expected to generate evidence that helps assess how interventions perform and how they can be improved, while also informing the development of new tools and strategies supporting malaria control and elimination.

Where is the research expected to be conducted?

The supported research is intended to be conducted primarily in countries where malaria is endemic.

How important is involvement from malaria-endemic country researchers and institutions?

It is a defining feature of this FOA. Applications must demonstrate significant involvement of local and regional researchers in study design, development, and execution, with meaningful roles in leadership, scientific decision-making, and implementation.

What kinds of proposals would be misaligned with the intent of the initiative?

The description indicates that proposals relying heavily on external leadership, without clear and substantive engagement and capacity integration in-country, would be misaligned with the intent of the program.

Who is eligible to apply?

Eligibility is broad and includes U.S. and non-U.S. organizations. Examples listed include various levels of government (state, county, city/township), special district governments, independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, tribal governments and tribal organizations (including those not federally recognized), public housing authorities/Indian housing authorities, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses) and small businesses, and other entities.

Are foreign (non-U.S.) organizations eligible?

Yes. The FOA highlights non-domestic (non-U.S.) entities (foreign organizations) as eligible applicants.

Are regional organizations eligible?

Yes. Regional organizations are explicitly listed among additional eligible groups.

Are U.S. territories or possessions eligible?

Yes. U.S. territories or possessions are included in the listed eligible groups.

Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are included among the additional eligible groups highlighted in the FOA.

Are minority-serving and tribal-serving institutions eligible?

Yes. The FOA highlights multiple categories of minority-serving and tribal-serving institutions as eligible, including HBCUs, Hispanic-serving institutions, AANAPISIs, Alaska Native and Native Hawaiian Serving Institutions, and Tribally Controlled Colleges and Universities.

What is the maximum award amount listed?

The award ceiling is listed as $800,000.

What is the Assistance Listing (CFDA) number for this opportunity?

The CFDA (Assistance Listing) number provided is 93.855.

What is the Funding Opportunity Number (FON)?

The Funding Opportunity Number is RFA AI 22 067.

What were the key dates shown in the FOA record?

The FOA record shows a creation date of November 22, 2022, and the original application closing date was May 4, 2023.

What kind of program structure is NIH trying to build through ICEMR?

The program is described as a network of multidisciplinary international research centers. It is designed to link basic, translational, and population-level research so findings can inform malaria control programs and the development and use of future tools and strategies.

What should applicants expect regarding coordination across the ICEMR network?

Because this is a cooperative agreement and is described as a networked program, applicants should plan for coordination across the broader ICEMR network, along with expectations around milestones and data sharing as part of how the program operates.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: F23AS00127 Cooperative Endangered Species Conservation Fund: Conservation Planning Assistance

Previous opportunity: Cooperative Agreement for CESU-affiliated Partner with Pacific Northwest Cooperative Ecosystem Studies Unit

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AI 22 067

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AI 22 067) also looked into and applied for these:

Funding Opportunity
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) Apply for PAR 23 054

Funding Number: PAR 23 054
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) Apply for PAR 23 053

Funding Number: PAR 23 053
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Mozambique Local Tuberculosis Response II Apply for 72065623 RFI TBCONTROL

Funding Number: 72065623 RFI TBCONTROL
Agency: Mozambique USAID-Maputo
Category: Health
Funding Amount: Case Dependent
Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) Apply for RFA MH 23 310

Funding Number: RFA MH 23 310
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Mozambique Local Tuberculosis Response II Apply for 720656 RFI TBCONTROL

Funding Number: 720656 RFI TBCONTROL
Agency: Mozambique USAID-Maputo
Category: Health
Funding Amount: Case Dependent
Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) Apply for PAR 22 256

Funding Number: PAR 22 256
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 23 065

Funding Number: PAR 23 065
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 23 003

Funding Number: RFA RM 23 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional) Apply for RFA OD 23 002

Funding Number: RFA OD 23 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 23 036

Funding Number: PAR 23 036
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) Apply for PAR 23 057

Funding Number: PAR 23 057
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional) Apply for RFA OD 23 005

Funding Number: RFA OD 23 005
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R61/R33 Clinical Trial Required) Apply for PAR 23 043

Funding Number: PAR 23 043
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional) Apply for RFA AT 23 008

Funding Number: RFA AT 23 008
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Interorgan Communication in Aging (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 005

Funding Number: RFA AG 24 005
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional) Apply for PAR 23 050

Funding Number: PAR 23 050
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed) Apply for RFA AI 22 075

Funding Number: RFA AI 22 075
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
NIH StrokeNet- Regional Coordinating Stroke Centers for year 2023 (U24 - Clinical Trials Not Allowed) Apply for RFA NS 23 010

Funding Number: RFA NS 23 010
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,750,000
NIH StrokeNet National Coordinating Center for year 2023 (U01 Clinical Trials Not Allowed) Apply for RFA NS 23 009

Funding Number: RFA NS 23 009
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,750,000
NIH StrokeNet National Data Management Center for year 2023 (U01 Clinical Trials Not Allowed) Apply for RFA NS 23 008

Funding Number: RFA NS 23 008
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 22 067", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: